Trump Acquires Palantir Shares Before Public Endorsement on Truth Social Ethics Records Reveal New York Fed Study Surging Gas Prices Disproportionately Strain LowerIncome Households JPMorgans Summer Reading List for HighNetWorth Clients Highlights AI and Leadership Trends GT Biopharma GTBP Q1 2026 Results Fall Short EPS 011 Revenue NA European Reindustrialisation Faces Funding Challenge Amid AI Investment Surge Berkshire Hathaway Revamps Portfolio 26 Billion Delta Stake and Major Alphabet Increase Media Ratings Chase The Financial Implications of Chris Hansens Primetime Era Ajmera Realty Shares Surge 96 on Strong FY26 Financial Results Citius Pharmaceuticals CTXR A Penny Stock Option Among Wall Street Analyst Favorites Jay Thakkar Recommends Three FO Stocks for ShortTerm as Nifty Faces Resistance at 24100 SPB Q1 2026 Earnings Strong EPS Beat Drives Share Gains Despite Missing Revenue Details Safe Pro Group Inc SPAI Q1 2026 Earnings WiderthanExpected Loss Reflects Investment Phase IN8bio Q1 2026 Earnings Narrowed Loss Beats Expectations as Development Pipeline Advances SLB Q1 2026 Earnings EPS Slightly Misses Estimates Amid Stable Operations FONR Q1 2025 Earnings Profitability Maintained Amid Limited Disclosure Rising Dragon Acquisition Corp RDAC Holds Steady Near 930 Amid SPAC Uncertainty Sunshine Biopharma SBFM Slides 116 as Support at 044 Comes into Focus Opendoor Technologies Warrants OPENL Slide 7 as Selling Pressure Intensifies Invesco Ltd IVZ Holds Near Support Amid Modest Decline Resistance Awaits IDE Shares Retreat Amid Broader Market Pressure Key Support Levels in Focus Workday WDAY Attracts Analyst Attention as a Potentially Undervalued AI Play Clipper Realty Inc CLPR Q1 2026 Earnings Profitability Achieved Amid Market Headwinds Align Technology ALGN Maintains Slight Advance as Shares Approach Key Resistance Level ATLO Q1 2026 Earnings EPS Beats Estimates by Nearly 6 Harrow Inc HROW Q1 2026 Earnings Significant EPS Miss Amid Operating Challenges Northeast Bank Q1 2026 Earnings EPS Surpasses Estimates by 94 as Stock Slips Slightly CRGO Q1 2026 Earnings EPS Misses Estimates as Stock Declines on WiderThanExpected Loss Halozyme Therapeutics Q1 2026 Earnings EPS Beat Drives Modest Positive Surprise Despite Flat Revenue Disclosure COCH Q1 2026 Earnings Narrower Loss Beats Estimates as Envoy Medical Advances Vivani Medical VANI Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction